Gargantilla, M.; López-Fernández, J.; Camarasa, M.-J.; Persoons, L.; Daelemans, D.; Priego, E.-M.; Pérez-Pérez, M.-J.
Inhibition of XPO-1 Mediated Nuclear Export through the Michael-Acceptor Character of Chalcones. Pharmaceuticals 2021, 14, 1131.
https://doi.org/10.3390/ph14111131
AMA Style
Gargantilla M, López-Fernández J, Camarasa M-J, Persoons L, Daelemans D, Priego E-M, Pérez-Pérez M-J.
Inhibition of XPO-1 Mediated Nuclear Export through the Michael-Acceptor Character of Chalcones. Pharmaceuticals. 2021; 14(11):1131.
https://doi.org/10.3390/ph14111131
Chicago/Turabian Style
Gargantilla, Marta, José López-Fernández, Maria-Jose Camarasa, Leentje Persoons, Dirk Daelemans, Eva-Maria Priego, and MarÃa-Jesús Pérez-Pérez.
2021. "Inhibition of XPO-1 Mediated Nuclear Export through the Michael-Acceptor Character of Chalcones" Pharmaceuticals 14, no. 11: 1131.
https://doi.org/10.3390/ph14111131
APA Style
Gargantilla, M., López-Fernández, J., Camarasa, M.-J., Persoons, L., Daelemans, D., Priego, E.-M., & Pérez-Pérez, M.-J.
(2021). Inhibition of XPO-1 Mediated Nuclear Export through the Michael-Acceptor Character of Chalcones. Pharmaceuticals, 14(11), 1131.
https://doi.org/10.3390/ph14111131